ONCOBETA®

OncoBeta is ISO 13485 & CE certified medical device company and has received regulatory approval from the Australian Therapeutic Goods Administration (TGA)... OncoBeta® GmbH with its headquarters located in Garching, near Munich, is a privately held medical device and radiochemical company specialized in the development and commercialization of state-of-the-art, innovative skin cancer therapies utilizing epidermal radioisotope applications. Since its foundation, OncoBeta® GmbH has concentrated its efforts on the development, regulatory approval(s) and commercialization of the epidermal radioisotope therapy Rhenium-SCT® (Skin Cancer Therapy), targeting non-melanoma skin cancers. Since then, OncoBeta® has successfully perfected the customized application and device management system in conformity with all health, safety, and environmental protection regulatory standards. OncoBeta® GmbH is European CE certified, TGA-Australia approved, certified by SAPHRA - South Africa and has filed for..

Also known as: OncoBeta® GmbH

Registration numbers: HRB 185976 (W)

VAT numbers: DE271823356

Primary location: Garching Germany